ARTICLE | Company News
Novartis sales and marketing update
August 22, 2016 7:00 AM UTC
The U.K.’s NICE issued draft guidance recommending against the use of Afinitor everolimus because it “did not have plausible potential to be cost effective,” even when offered an undisclosed discount...